(million yen)
2020/07 2021/07 2022/07 2023/07 2024/07 2025/07
FY 20,50832,81533,91126,40020,35916,160
3Q 14,57423,76625,89620,60915,43912,500
2Q 9,23215,31017,97014,25810,6498,528
1Q 4,3427,2109,8657,3915,2644,230
(million yen)
2020/07 2021/07 2022/07 2023/07 2024/07 2025/07
FY 1,6534,6802,414-611139617
3Q 8304,4281,9574231,266
2Q -3992,4612,248109-205977
1Q -2118882,074-244-35622
(million yen)
2020/07 2021/07 2022/07 2023/07 2024/07 2025/07
FY 1,6354,6532,572-631161599
3Q 8194,4162,14143441,214
2Q -4052,4542,32195-199970
1Q -2138662,132-224-26625
(million yen)
2020/07 2021/07 2022/07 2023/07 2024/07 2025/07
FY 1,1432,7931,424-733-1,483471
3Q 5792,8271,222-153-1,450762
2Q -2851,5731,360-26-1,685581
1Q -1505501,320-198-35414
(yen)
2020/07 2021/07 2022/07 2023/07 2024/07 2025/07
FY 142.93326.87163.35-84.17-170.1054.10
3Q 72.45333.15140.18-17.58-166.3787.49
2Q -35.68187.81156.01-2.98-193.2566.67
1Q -18.8068.52151.43-22.71-4.0947.49
(million yen)
2020/07 2021/07 2022/07 2023/07 2024/07 2025/07
FY 6,84813,07112,30012,13511,00210,140
3Q 5,82412,38612,75513,26211,16910,682
2Q 5,51510,39513,68913,72610,62510,958
1Q 4,1979,81015,66112,48312,90811,165
(million yen)
2020/07 2021/07 2022/07 2023/07 2024/07 2025/07
FY 1,4496,9038,3487,6096,1246,610
3Q 8866,9438,1428,1826,1566,903
2Q 205,6888,2658,3095,9236,709
1Q 1564,6668,2148,1537,5736,536
(%)
2020/07 2021/07 2022/07 2023/07 2024/07 2025/07
FY 21.252.867.962.755.765.1
3Q 15.256.163.861.755.164.6
2Q 0.454.760.460.555.761.2
1Q 3.747.652.565.358.758.5

Note 1: The Company conducted a 20-for-1 stock split of shares of common stock on August 29, 2020, based on a resolution passed at an extraordinary meeting of the Board of Directors held on August 20, 2020. Earnings per share are retroactively presented for prior periods.

Note 2: The Company has prepared consolidated financial statements since the second quarter of the fiscal year ended July 31, 2021. Figures prior to the second quarter of the fiscal year ended July 31, 2021 are those of Premier Anti-Aging on a non-consolidated basis.

Caution

  • These data are prepared based on the financial results reports.

  • The frequency of updates may change in accordance with changes to the format of the financial results reports.

  • Please see the financial results reports and other materials for detailed information regarding the settlement of accounts.

  • The contents of these data will not immediately reflect corrections to the financial results reports when announced.

  • While we pay due caution to the conversion of data for the posting, please note that there is a possibility that errors may occur in the information due to uncontrollable circumstances, such as the unauthorized alteration of contents by a third party or mechanical defects resulting from equipment malfunction.

  • Service provided by Nomura Investor Relations Co., Ltd.

Powered by